ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Participants needed for HSDD drug study (Addyi®)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 200443" data-attributes="member: 13851"><p>[URL unfurl="true"]https://www.bcm.edu/news/participants-needed-for-hsdd-drug-study[/URL]</p><p></p><p><strong><em>Researchers at Baylor College of Medicine are <u>conducting a study to determine if a drug will increase sexual desire in men with Hypoactive Sexual Desire Disorder (HSDD)</u>. The pilot randomized placebo-controlled study will include 60 men: 30 treatment subjects and 30 placebo subjects.</em></strong></p><p><strong><em></em></strong></p><p><strong><em><u>The purpose of this study is to determine if the study drug, Flibanserin (ADDYI), will increase sexual desire in men with HSDD</u>. Study participants will be divided into two arms. Arm 1 participants will receive the study drug to be taken by mouth once a night every night. Arm 2 participants will receive a placebo drug to be taken by mouth once a night every night.</em></strong></p><p><strong><em></em></strong></p><p><strong><em>Inclusion criteria for the study consist of men ages 18 to 69 years old. Based on patient questionnaires, additional criteria include:</em></strong></p><p> </p><p></p><ul> <li data-xf-list-type="ul"><em><strong>Men that are distressed by their low libido</strong></em></li> <li data-xf-list-type="ul"><em><strong>Men who are not depressed</strong></em></li> <li data-xf-list-type="ul"><em><strong>Men with good erectile function</strong></em></li> <li data-xf-list-type="ul"><em><strong>Men with normal testosterone and liver function values</strong></em></li> <li data-xf-list-type="ul"><em><strong>Men who are satisfied in their relationship or with their partners</strong></em></li> <li data-xf-list-type="ul"><em><strong>Men or their female partners must be willing to use one form of contraception throughout the study and 30 days after the final study visit</strong></em></li> <li data-xf-list-type="ul"><strong><em>Willing to give informed consent</em></strong></li> </ul><p></p><p><strong><em>Participants are required to make four visits to the <a href="https://www.bcm.edu/node/104181" target="_blank">Scott Department of Urology</a> at Baylor. The first is a screening that includes a physical, vital signs, blood drawings, concomitant medications (medication participants are taking prior to participating in the study), and questionnaires. Participants will make a second visit nearly a week later, consisting of a physical, vital signs, randomization, drug dispensing, pill diary dispensing, and concomitant medications. The third visit entails a physical, vital signs, blood drawings, and drug accountability, pill diary review, and medication dispensing. The final visit at the end of the study also includes physical, vital signs, and blood drawings, as well as concomitant medications, questionnaires, drug accountability, and a pill diary review.</em></strong></p><p></p><p>The study will take place at 7200 Cambridge St. Houston, Texas 77030 on the 10th floor. For more information, contact <strong>Haarika Gudlavalleti at 713-798-4396 or <a href="mailto:Haarika.Gudlavalleti@bcm.edu">Haarika.Gudlavalleti@bcm.edu</a></strong></p></blockquote><p></p>
[QUOTE="madman, post: 200443, member: 13851"] [URL unfurl="true"]https://www.bcm.edu/news/participants-needed-for-hsdd-drug-study[/URL] [B][I]Researchers at Baylor College of Medicine are [U]conducting a study to determine if a drug will increase sexual desire in men with Hypoactive Sexual Desire Disorder (HSDD)[/U]. The pilot randomized placebo-controlled study will include 60 men: 30 treatment subjects and 30 placebo subjects. [U]The purpose of this study is to determine if the study drug, Flibanserin (ADDYI), will increase sexual desire in men with HSDD[/U]. Study participants will be divided into two arms. Arm 1 participants will receive the study drug to be taken by mouth once a night every night. Arm 2 participants will receive a placebo drug to be taken by mouth once a night every night. Inclusion criteria for the study consist of men ages 18 to 69 years old. Based on patient questionnaires, additional criteria include:[/I][/B] [LIST] [*][I][B]Men that are distressed by their low libido[/B][/I] [*][I][B]Men who are not depressed[/B][/I] [*][I][B]Men with good erectile function[/B][/I] [*][I][B]Men with normal testosterone and liver function values[/B][/I] [*][I][B]Men who are satisfied in their relationship or with their partners[/B][/I] [*][I][B]Men or their female partners must be willing to use one form of contraception throughout the study and 30 days after the final study visit[/B][/I] [*][B][I]Willing to give informed consent[/I][/B] [/LIST] [B][I]Participants are required to make four visits to the [URL='https://www.bcm.edu/node/104181']Scott Department of Urology[/URL] at Baylor. The first is a screening that includes a physical, vital signs, blood drawings, concomitant medications (medication participants are taking prior to participating in the study), and questionnaires. Participants will make a second visit nearly a week later, consisting of a physical, vital signs, randomization, drug dispensing, pill diary dispensing, and concomitant medications. The third visit entails a physical, vital signs, blood drawings, and drug accountability, pill diary review, and medication dispensing. The final visit at the end of the study also includes physical, vital signs, and blood drawings, as well as concomitant medications, questionnaires, drug accountability, and a pill diary review.[/I][/B] The study will take place at 7200 Cambridge St. Houston, Texas 77030 on the 10th floor. For more information, contact [B]Haarika Gudlavalleti at 713-798-4396 or [EMAIL]Haarika.Gudlavalleti@bcm.edu[/EMAIL][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Participants needed for HSDD drug study (Addyi®)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top